However, in general, Nrf2 activation may prevent the progression of LN through the inhibition of oxidative injury and by negatively regulating the NF-κB pathway via signaling through TLR4 and the expression of high-mobility group box 1 (HMGB1) [48,49]. The gene discussed is NFE2L2; the disease is lobular neoplasia.